Login to Your Account



Compound Secures $12M Series A Round To Drive Adzyme Research

By Aaron Lorenzo


Thursday, May 29, 2003
Compound Therapeutics Inc. has hit the ground running after closing a $12 million Series A round of financing.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription